News

Deal Announcements

Dicerna Pharma Raises Additional Venture Capital Funds

Monday, October 25, 2010 5:53:00 AM PDT | VentureDeal Staff
Watertown, Massachusetts  --  RNA pharmaceutical company Dicerna Pharmaceuticals has garnered $4 million in additional venture capital financing in its second round.

Dicerna is developing therapeutics based on Dicer substrate technology that makes use of the RNA interference mechanism.

SR One made the additional investment, which will be used to advance the company's in-house program in oncology.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1